What did Veritas Capital pay for GE Healthcare Technology Unit (Virence Health)?

$1.05B, equivalent to 7.0× EBITDA / 2.40× revenue. Target revenue was approximately $440.0M. Target EBITDA was approximately $150.0M.

ACQUIRED · 2018

Who Acquired GE Healthcare Technology Unit (Virence Health)?

Veritas Capital · $1.05B· 7.0× EBITDA

The acquisition

GE Healthcare Technology Unit (Virence Health) was acquired by Veritas Capital in 2018 for $1.05B. The deal was priced at 7.0× EBITDA / 2.40× revenue.

GE Healthcare Technology Unit (Virence Health) at time of acquisition

Revenue

$440.0M

EBITDA

$150.0M

Deal value

$1.05B

EV / EBITDA

7.0×

Other acquisitions by Veritas Capital

Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.

DXC Technology Healthcare Unit (Gainwell) · 2020 · $5.00B

Similar healthcare it acquisitions

Eucalyptus · acquired by Hims & Hers Health, Inc. in 2026 · $1.15B
Gleamer SAS · acquired by RadNet, Inc. in 2026 · $251.6M
HealthEZ · acquired by Blue Cross Blue Shield of New Jersey in 2026 · $360.0M
Unbound Medicine · acquired by MPS Ltd in 2026 · $16.5M
AccessOne · acquired by Phreesia, Inc. in 2025 · $160.0M

Run a valuation for a similar healthcare it business

Three fields, instant range, backed by 25,592 real M&A transactions including this one.

Open the healthcare it calculator →